Bnai Zion Medical Center   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Haifa Israel (1922)

Organization Overview

First Clinical Trial
2002
NCT00275418
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

affiliated with Bnai Zion MC | Bani Zion Medical Center Haifa ISRAEL | Bnai Zion Medical Center | Bnai Zion Medical Center, Haifa | Bnai-zion medical center, Haifa, Israel | Bnai Zion Medical Center, Haifa, Israel | Bnai-Zion Medical Center, Haifa, Israel | Bnei- Zion MC. Israel | Department of Neonatology, Bnai Zion Medical Center | Department of Pediatrics, Pediatric Gastroenterology, Bnai Zion Medical Center | Ethicla Committee Bnai Zion Medical Center | sammour.rami

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 2)

Arthritis (Phase 3)

Arthritis, Juvenile (Phase 2)

Bronchiolitis (Phase 1)

Bronchiolitis, Viral (Phase 1)

Bronchopulmonary Dysplasia (Phase 2)

Carcinoma (Phase 1)

Carcinoma, Transitional Cell (Phase 1)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Crohn Disease (Phase 3)

Depression (Phase 2)

Enterocolitis (Phase 2)

Enterocolitis, Necrotizing (Phase 2)

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

Hyperplasia (Phase 2)

Premature Birth (Phase 2)

Renal Insufficiency (Phase 2)

Spondylitis (Phase 4)

Spondylitis, Ankylosing (Phase 4)

Still's Disease, Adult-Onset (Phase 2)

Tachypnea (Phase 2)

Transient Tachypnea of the Newborn (Phase 2)

Ulcer (Phase 3)

Urinary Bladder Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 26
  • # of Trial APIs: 33